Observable data points shared across all narratives
South Africa is set to begin rolling out a new anti-HIV vaccine in six weeks despite significant funding cuts that have weakened the healthcare system needed for distribution. These cuts, associated with policies from former US President Donald Trump, threaten to slow the vaccine's delivery and reduce its effectiveness in preventing HIV. The situation raises concerns about how well the vaccine can reach millions at risk amid strained resources.